Alternatives to Ukko

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Develops a computational model of the human body for drug discovery and development.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

AI platform for accelerating novel peptide therapeutic discovery and development.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Developing novel diagnostics to predict patient response to immunotherapy.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.